Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Published in: Heart and Vessels 4/2009

01-07-2009 | Original Article

Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure

Authors: Heng-Chen Yao, Shu-Qin Liu, Ke Yu, Min Zhou, Le-Xin Wang

Published in: Heart and Vessels | Issue 4/2009

Login to get access
Metadata
Title
Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure
Authors
Heng-Chen Yao
Shu-Qin Liu
Ke Yu
Min Zhou
Le-Xin Wang
Publication date
01-07-2009
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 4/2009
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-008-1123-0

Other articles of this Issue 4/2009

Heart and Vessels 4/2009 Go to the issue

Original Article

Baseline inflammation is not predictive of periprocedural troponin elevation after elective percutaneous coronary intervention

Original Article

Olmesartan ameliorates myocardial function independent of blood pressure control in patients with mild-to-moderate hypertension

Original Article

Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease

Original Article

Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure

Case Report

Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel

Original Article

Presence of irregularity in region between −1115 and −784 nt in P1 promoter of Insulin-Like Growth Factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits